The impact of education level on all-cause mortality in patients with atrial fibrillation.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
25 Oct 2024
Historique:
received: 25 03 2024
accepted: 26 09 2024
medline: 26 10 2024
pubmed: 26 10 2024
entrez: 25 10 2024
Statut: epublish

Résumé

The association of socioeconomic status with cardiovascular morbidity and mortality is well known, but data on the influence of education level on mortality in individuals with atrial fibrillation (AF) are scarce. We investigated education level as a predictor of all-cause mortality in patients diagnosed with AF. This retrospective cohort study used a database created from several Swedish nationwide registries to identify all patients hospitalized with a diagnosis of AF hospitalized from 1995 to 2008. Education level was categorized as primary, secondary, and academic. All-cause mortality risk was estimated in subpopulations defined by the Charlson Comorbidity Index and several comorbidities. A total of 272,182 patients (56% male; mean age 72 ± 10 years) were followed for five years. Cox regression models showed a reduction in all-cause mortality risk with increased education level. Hazard ratios (HR) relative to primary education remained significant after stratification and adjustment for several confounders: secondary education HR = 0.88; 95% CI: 0.86-0.89; P < 0.001; academic education HR = 0.70; 95% CI: 0.67-0.72; P < 0.001. Subpopulation analyses confirmed a significant reduction in relative risk with higher education level. Targeted screening and education programs could be effective in reducing mortality in AF patients with fewer years of formal education.

Identifiants

pubmed: 39455584
doi: 10.1038/s41598-024-74478-2
pii: 10.1038/s41598-024-74478-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

25386

Informations de copyright

© 2024. The Author(s).

Références

Rangarajan, S. et al. Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study. Lancet Glob Heal 7, e748-60 (2019).
doi: 10.1016/S2214-109X(19)30045-2
Havranek, E. P. et al. Social determinants of risk and outcomes for cardiovascular disease: A scientific statement from the American Heart Association. Circulation 132, 873–98 (2015).
doi: 10.1161/CIR.0000000000000228 pubmed: 26240271
Shavers, V. L. Measurement of socioeconomic status in health disparities research. J Natl Med Assoc 99, 1013–23 (2007).
pubmed: 17913111 pmcid: 2575866
Goli, N. M. et al. Educational attainment is associated with atrial fibrillation symptom severity. PACE - Pacing Clin Electrophysiol 35, 1090–6 (2012).
doi: 10.1111/j.1540-8159.2012.03482.x pubmed: 22817646
Galobardes, B. et al. Indicators of socioeconomic position (part 1). J Epidemiol Community Health 60, 7–12 (2006).
doi: 10.1136/jech.2004.023531 pubmed: 16361448 pmcid: 2465546
Chung, S.-C. et al. Atrial fibrillation epidemiology, disparity and healthcare contacts: a population-wide study of 5.6 million individuals. Lancet Reg Heal Eur 7, 100157 (2021).
doi: 10.1016/j.lanepe.2021.100157
Hagengaard, L. et al. Socioeconomic differences in outcomes after hospital admission for atrial fibrillation or flutter. Eur Hear journal Qual care Clin outcomes 7, 295–303 (2021).
doi: 10.1093/ehjqcco/qcz053
Hindricks, G. et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 42, 373–498 (2021).
doi: 10.1093/eurheartj/ehaa612 pubmed: 32860505
Lunde, E. D. et al. Associations between socioeconomic status, atrial fibrillation, and outcomes: a systematic review. Expert Rev Cardiovasc Ther 16, 857–73 (2018).
doi: 10.1080/14779072.2018.1533118 pubmed: 30293472
Mou, L. et al. Lifetime Risk of Atrial Fibrillation by Race and Socioeconomic Status. Circ Arrhythmia Electrophysiol 11, 139–48 (2018).
doi: 10.1161/CIRCEP.118.006350
Christensen, A. V. et al. Educational inequality in cardiovascular disease depends on diagnosis: A nationwide register based study from Denmark. Eur J Prev Cardiol 23, 826–33 (2016).
doi: 10.1177/2047487315613665 pubmed: 26538614
Andersson, T. et al. All-cause mortality in 272 186 patients hospitalized with incident atrial fibrillation 1995–2008: A Swedish nationwide long-term case-control study. Eur Heart J 34, 1061–7 (2013).
doi: 10.1093/eurheartj/ehs469 pubmed: 23321349 pmcid: 3618889
Ludvigsson JF, Andersson E, Ekbom A. et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 11  https://doi.org/10.1186/1471-2458-11-450 (2011).
Mary, C. & Ronald, M. A new method of classifying prognostic comorbidity in longitudinal studies: Developement and validation. J Chronic Dis 40, 373–83 (1987).
doi: 10.1016/0021-9681(87)90171-8
Rashid, M. et al. Impact of co-morbid burden on mortality in patients with coronary heart disease, heart failure, and cerebrovascular accident: a systematic review and meta-analysis. Eur Hear J Qual Care Clin outcomes 3, 20–36 (2017).
doi: 10.1093/ehjqcco/qcw025
Quan, H. et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43, 1130–9 (2005).
doi: 10.1097/01.mlr.0000182534.19832.83 pubmed: 16224307
Lip, G. Y. H. et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on atrial fibrillation. Chest 137, 263–72 (2010).
doi: 10.1378/chest.09-1584 pubmed: 19762550
Rix TA, Riahi S, Overvad K. et al. Validity of the diagnoses atrial fibrillation and atrial flutter in a Danish patient registry in a Danish patient registry. 7431   https://doi.org/10.3109/14017431.2012.673728 (2012).
Harrell, & Frank E. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis, Vol. 608 (Springer, New York, 2001).
Belias, M. et al. Predicting personalised absolute treatment effects in individual participant data meta-analysis: An introduction to splines. Res Synth Methods 13, 255–83 (2022).
doi: 10.1002/jrsm.1546 pubmed: 35000297 pmcid: 9303665
World Medical Association Declaration of Helsinki. ethical principles for medical research involving human subjects. JAMA 310, 2191–4 (2013).
doi: 10.1001/jama.2013.281053
Patsiou, V. et al. Education level predicts mortality and morbidity in hospitalised patients with atrial fibrillation. Hell J Cardiol 65, 19–24 (2022).
doi: 10.1016/j.hjc.2022.03.005
Akerkar, R. et al. Educational inequalities in mortality of patients with atrial fibrillation in Norway. Scand Cardiovasc J 51, 82–7 (2017).
doi: 10.1080/14017431.2016.1268711 pubmed: 27918197
Wändell, P. et al. Socioeconomic factors and mortality in patients with atrial fibrillation—a cohort study in Swedish primary care. Eur J Public Health 28, 1103–9 (2018).
doi: 10.1093/eurpub/cky075 pubmed: 29746622 pmcid: 6241208
Chapa, D. W. et al. Gender differences in stroke, mortality, and hospitalization among patients with atrial fibrillation: A systematic review. Hear Lung J Acute Crit Care 44, 189–98 (2015).
doi: 10.1016/j.hrtlng.2015.01.008
Goli, N. M. et al. Educational Attainment Is Associated with Atrial Fibrillation Symptom Severity. Pacing Clin Electrophysiol 35, 1090–6 (2012).
doi: 10.1111/j.1540-8159.2012.03482.x pubmed: 22817646
Gleason, K. T. et al. Association of sex, age and education level with patient reported outcomes in atrial fibrillation. BMC Cardiovasc Disord 19, 85 (2019).
doi: 10.1186/s12872-019-1059-6 pubmed: 30953478 pmcid: 6451250
Raparelli, V. et al. Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study. Intern Emerg Med 9, 861–70 (2014).
doi: 10.1007/s11739-014-1096-1 pubmed: 24990547
Barcelo, A. et al. The role of education on Cancer amenable mortality among non-Hispanic blacks & non-Hispanic whites in the United States (1989–2018). BMC Cancer 21, 1–13 (2021).
doi: 10.1186/s12885-021-08633-7
De Vries, E., Arroyave, I. & Pardo, C. Time trends in educational inequalities in cancer mortality in Colombia, 1998–2012. BMJ Open 6, 1–9 (2016).
doi: 10.1136/bmjopen-2015-008985
Che B, Shen S, Zhu Z, et al. Education level and long-term mortality, recurrent stroke, and cardiovascular events in patients with ischemic stroke. J Am Heart Assoc.  9.  https://doi.org/10.1161/JAHA.120.016671 (2020).
Notara, V. et al. The impact of educational status on 10-year (2004–2014) cardiovascular disease prognosis and all-cause mortality among acute coronary syndrome patients in the Greek acute coronary syndrome (GREECS) longitudinal study. J Prev Med Public Heal 49, 220–9 (2016).
doi: 10.3961/jpmph.16.005
Corica, B. et al. Educational status affects prognosis of patients with heart failure with reduced ejection fraction: A post-hoc analysis from the WARCEF trial. Eur J Clin Invest 54, 1–10 (2024).
doi: 10.1111/eci.14152
Nabauer, M. et al. Prognostic markers of all-cause mortality in patients with atrial fibrillation: Data from the prospective long-term registry of the German Atrial Fibrillation NETwork (AFNET). EP Eur 23, 1903–12 (2021).
Biancari, F. et al. Income and outcomes of patients with incident atrial fibrillation. J Epidemiol Community Health 76, 736–42 (2022).
doi: 10.1136/jech-2022-219190 pubmed: 35705362

Auteurs

Áron Sztaniszláv (Á)

Department of Cardiology, School of Medical Sciences, Örebro University, Örebro, Sweden. aron-jozsef.sztaniszlav@regionorebrolan.se.

Anna Björkenheim (A)

Department of Cardiology, School of Medical Sciences, Örebro University, Örebro, Sweden.

Anders Magnuson (A)

Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

Ing-Liss Bryngelsson (IL)

Department of Occupational and Environmental Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

Nils Edvardsson (N)

Sahlgrenska Academy at Sahlgrenska University Hospital, Gothenburg, Sweden.

Dritan Poci (D)

Department of Cardiology, School of Medical Sciences, Örebro University, Örebro, Sweden.
Sahlgrenska Academy at Sahlgrenska University Hospital, Gothenburg, Sweden.
Department of Clinical Physiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH